Prostate Cancer
Our group is concerned with the identification of markers for
therapeutic responsiveness, prognostic markers, and new markers of
early prostate disease. We take a multidisciplinary approach that
utilises expertise from a number of cancer researchers within and
outside the Garvan, as well as clinicians and pathologists. Our
research aims to identify genes and pathways whose expression changes
can predict the development of aggressive life-threatening prostate
cancer or resistance to chemotherapy used for the treatment of advanced
stage prostate cancer.
Staff
 Senior Research OfficerDr Maret Boehm |
Senior Research Officer Dr Lisa Horvath |
 Senior Research OfficerDr Jack Zhao |
|
 Research AssistantAlice Boulghourjian |
 Research AssistantChristina Lui |
 Research AssistantRuth Pe Benito |
 Clinical Research
Co-ordinatorAnne-Maree Haynes |
| Research Assistant Christina Lui |
 PhD StudentPaul Chen |
| Student Kate Mahon |
Visiting Scientists Dr Ruban Thanigasalam Associate Professor John Grygiel Dr Krishan Rasiah Associate Professor James Kench Professor Soon Lee Associate Professor Phil Stricker |
| Data Clerks Sara Bassin Sally Clarke Emma Fist Claire Lawley Ben Moore Sarah Zardawi |
News
Nuns on the Run from Dubbo to Darlinghurst for Cancer
MEDIA RELEASE:
19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
Garvan and St Vincent’s to Build $100 million Australian Cancer Centre
MEDIA RELEASE:
22 Oct 2008
The Garvan Institute of Medical Research and St Vincents & Mater Health Sydney will today announce plans to jointly establish a new $100 million Cancer Centre within the St Vincent’s Research Precinct. The Garvan St Vincent’s Campus Cancer Centre (GSVCCC) will integrate internationally acclaimed cancer research with best practice cancer services, enabling research findings to move quickly into patient care.
New prostate cancer marker helps identify men whose cancer is likely to spread
05 Oct 2006
Prostate cancer researchers at Sydney’s Garvan Institute found a new marker for identifying aggressive prostate cancers.
